» Articles » PMID: 17879278

Early Bacterial Dependent Induction of Inducible Nitric Oxide Synthase (iNOS) in Epithelial Cells Upon Transfer of CD45RB(high) CD4(+) T Cells in a Model for Experimental Colitis

Overview
Specialty Gastroenterology
Date 2007 Sep 20
PMID 17879278
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Both the role of inducible nitric oxide synthase (iNOS) in the development of inflammatory bowel disease (IBD) as well as the molecular details governing its mucosal induction remain unclear.

Methods: In the present study we evaluated the role of the residing intestinal microflora in the induction of epithelial iNOS upon transfer of CD45RB(high) CD4(+) T cells to SCID mice. CB-17 SCID mice were reared with conventional flora (CNV) or germfree CB-17 SCID mice were monoassociated with Helicobacter muridarum, act A(-) mutant Listeria monocytogenes, segmented filamentous bacteria (SFB), or Ochrobactrum anthropi.

Results: Within 2 weeks CNV SCID mice injected with CD45RB(high) CD4(+) T cells showed a focal, epithelial iNOS expression on the apical site of villi that preceded the infiltration of CD4(+) T cells and cytokine production followed by extension of this expression to the entire surface along the whole crypt axis as the colitis progressed. SCID mice monoassociated with H. muridarum developed a severe colitis and showed high epithelial iNOS expression. CNV-SCID mice without T cells and SCID mice monoassociated with SFB did not show any iNOS expression, whereas SCID mice monoassociated with act A(-) mutant L. monocytogenes and O. anthropi showed some scattered epithelial iNOS staining on the apical site of a few villi, but none of these mice developed colitis.

Conclusions: These findings demonstrate that the expression of epithelial iNOS is highly bacterium-specific and correlates with the severity of disease, suggesting an important role for this enzyme in the development of IBD.

Citing Articles

Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1.

Han J, Li W, Shi G, Huang Y, Sun X, Sun N Mediators Inflamm. 2022; 2022:9129984.

PMID: 35431653 PMC: 9012613. DOI: 10.1155/2022/9129984.


Immune and microRNA responses to infection and indole-3-carbinol during colitis.

Raheem Alkarkoushi R, Hui Y, Tavakoli A, Singh U, Nagarkatti P, Nagarkatti M World J Gastroenterol. 2020; 26(32):4763-4785.

PMID: 32921956 PMC: 7459201. DOI: 10.3748/wjg.v26.i32.4763.


PD-1 deficiency protects experimental colitis via alteration of gut microbiota.

Park S, Kim J, Song M, Sung Y, Lee S, Park Y BMB Rep. 2017; 50(11):578-583.

PMID: 29065967 PMC: 5720472. DOI: 10.5483/bmbrep.2017.50.11.165.


Regulation of autoimmune myocarditis by host responses to the microbiome.

Barin J, Talor M, Diny N, Ong S, Schaub J, Gebremariam E Exp Mol Pathol. 2017; 103(2):141-152.

PMID: 28822770 PMC: 5721523. DOI: 10.1016/j.yexmp.2017.08.003.


Gut microbial diversity in health and disease: experience of healthy Indian subjects, and colon carcinoma and inflammatory bowel disease patients.

Bamola V, Ghosh A, Kapardar R, Lal B, Cheema S, Sarma P Microb Ecol Health Dis. 2017; 28(1):1322447.

PMID: 28588430 PMC: 5444350. DOI: 10.1080/16512235.2017.1322447.